03/13/2020 12:00 AM EDT
Source: Australian Government. Published: 3/13/2020. This web page, updated on March 13, 2020, provides a collection of resources, information, and guidance for health professionals, including aged care providers, pathology providers and healthcare managers, about the novel coronavirus (COVID-19). (Text)
03/12/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/12/2020. This interim guidance, updated on March 12, 2020, is intended primarily for administrators of public and private childcare programs and K-12 schools in the United States to help childcare programs, schools, and their partners understand how to help prevent the transmission of COVID-19 (coronavirus) within childcare and school communities and facilities. It also aims to help childcare programs, schools, and partners react quickly should a case be identified. The guidance includes considerations to help administrators plan for the continuity of teaching and learning if there is community spread of COVID-19. (Text)
03/12/2020 12:00 AM EDT
Source: American Academy of Pediatrics (AAP). Published: 3/12/2020. This one-hour, two-minute presentation discusses Managing Infectious Diseases in Early Education and Child Care Settings, a tool and curriculum. The tool provides three modules for Understanding Infectious Diseases, Preventing Infectious Diseases, and Recognizing and Managing Infectious Diseases. (Video or Multimedia)
03/12/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Center for Preparedness and Response (CDC CPR). Published: 3/12/2020. On this 54-minute Clinician Outreach and Communication Activity (COCA) call, presenters focus on current information about COVID-19 (coronavirus) as it relates to children and pregnant women. Topics include infection prevention and control measures in inpatient obstetric healthcare settings, and resources available to care for pediatric patients. (Video or Multimedia)
03/12/2020 12:00 AM EDT
Source: Centers for Medicare and Medicaid Services, Children's Health Insurance Program (CMS CHIP). Published: 3/12/2020. This 10-page document provides answers to frequently asked questions about COVID-19 (coronavirus) for state Medicaid and Children’s Health Insurance Program (CHIP) Agencies. Topics are Emergency Preparedness and Response, Eligibility and Enrollment Flexibilities, Benefit Flexibilities, Cost-Sharing Flexibilities, Financing Flexibilities, Workforce Flexibilities, and Miscellaneous. (PDF)
03/11/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 3/11/2020. This web page answers frequently asked questions about COVID-19 (coronavirus) and mass gatherings. Topics include how large a meeting or event needs to be in order to be a “mass gathering;" factors organizers and health authorities should look at when assessing whether the risks are acceptable or not; and where to find more advice about mass gatherings and health risks. (Text)
03/09/2020 12:00 AM EDT
Source: Royal College of Obstetricians and Gynaecologists. Published: 3/9/2020. This web page provides two resources about coronavirus (COVID-19) infection and pregnancy: a document on Coronavirus (COVID-19) Infection in Pregnancy: Information for Healthcare Professionals; and a page of frequently asked questions and information for pregnant women and their families. (Text)
03/09/2020 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 3/9/2020. This four-page form is a prehospital readiness checklist for COVID-19 (coronavirus) with components, objective, and enrollment actions; these are to be checked as complete, incomplete, or in process. (PDF)
03/07/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 3/7/2020. This six-page document provides guidance for responding to community transmission of COVID-19 (coronavirus). It also compiles technical guidance for government authorities, health workers, and other key stakeholders to guide response to community spread. It will be updated as new information or technical guidance become available. For countries that are already preparing or responding, this document can also serve as a checklist to identify any remaining gaps. (PDF)
03/05/2020 12:00 AM EST
Source: Association of American Medical Colleges (AAMC). Published: 3/5/2020. This three-page document was developed to guide medical student involvement and interactions with patient care and health care teams during the coronavirus (COVID-19) outbreak. A group of subject matter experts discussed issues related to nonclinical (classroom) interactions, introductory clinical skills courses, and clinical rotations and interactions, and offered the considerations in this document. (PDF)
03/04/2020 12:00 AM EST
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 3/4/2020. The list of medical devices identified in this eight-page document is the minimum required to support health care providers, intensive care unit managers, and Ministries of Health to appropriately manage a suspected or confirmed COVID-19 (coronavirus) patient in a health care setting. A table provides a technical description and specifications for each item. (PDF)
03/01/2020 12:00 AM EST
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 3/2020. This four-page document, updated in March 2020, provides parents, caregivers, and teachers with strategies for helping children manage their stress during an infectious disease outbreak. It describes potential reactions among youth and the support adults can provide to help them. (PDF)
03/01/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 3/2020. This 10-page document aims to provide guidance to European Union/European Economic Area (EU/EEA) healthcare facilities and healthcare providers on infection prevention and control measures during the management of suspected and confirmed cases of COVID-19 (coronavirus) infection in healthcare settings, including long-term care facilities. It also offers guidance on the management of specimens in laboratories in the EU/EEA. This is an update of the ECDC guidance from February 2020. (PDF)
02/27/2020 12:00 AM EST
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 2/27/2020. This 18-page document is a tool to help national authorities to develop or revise national pandemic preparedness and response plans to COVID‑19 (coronavirus). It has been developed to take into account the COVID-19 interim guidelines and the World Health Organization (WHO) guidance on topics related to pandemic influenza and public health emergency planning. Each section of the document presents a checklist of suggested planning actions that countries can take in order to be better prepared for a pandemic. (PDF)
02/06/2020 12:00 AM EST
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 2/6/2020. The precautions described in this four-page document are recommended for the care of patients with suspected or confirmed cases of coronavirus (COVID-19). Recommendations are for any suspected or confirmed cases of COVID-19: standard + contact + droplet precautions; for any suspected or confirmed cases of COVID-19 and aerosol-generating procedures (AGP): standard + contact + airborne precautions. (PDF)
02/01/2020 12:00 AM EST
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 2/1/2020. This five-page guidance for laboratories about provides coronavirus (COVID-19) information on suspected case definition; specimen collection and shipment; effective usage of global laboratory networking; testing of COVID-19 in reference laboratories; and reporting of cases and test results. (PDF)
01/28/2020 12:00 AM EST
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 1/28/2020. This 10-page document provides laboratory biosafety guidelines for the handling and transport of samples associated with the novel coronavirus (COVID-19) and details why it is necessary to maintain and strengthen biosafety measures, including personal protection procedures, to work with samples from suspected cases of respiratory pathogen infection. (PDF)
No hay comentarios:
Publicar un comentario